Tag Archives: ImmunoCellular

ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) is one of the week’s biggest biotech runners, up close to 200% on the Monday open. At a glance, there doesn’t look to be too much we can pin the gains on – there has been no news...

Sign Up Now For Our FREE Small Cap Newsletter